Many states have had prescription drug monitoring programs implemented for years, and more still are preparing to so. These data sharing programs at the pharmacy level have helped to reduce the amount of prescription drug fraud in America, but there have also been problems with pills being diverted before reaching pharmacies or doctors offices.
A new bill that passed the U.S. House of Representatives and the Senate is expected to be signed into law by the President that will track pharmaceuticals from manufacture to sale. The intended purpose of the Drug Quality and Security Act is more to prohibit counterfeit prescriptions from entering the market. It is sort of a support for drug manufacturers from the country to not allow the sale of cheaper prescriptions from another country as well.
In a statement from the Pharmaceutical Research and Manufacturers of America (PhRMA), President and CEO John Castellani wrote, “The counterfeiting of prescription drugs is on the rise within the United States but oftentimes goes unnoticed or unreported, leaving many Americans unaware of this problem. In fact, some experts have cited the counterfeiting of these medicines as even more lucrative than the trafficking of illegal drugs like heroin and cocaine.”
Another unintended bonus from this Act should also be that pills are tracked from inception so that they are not diverted or so that law enforcement officials can easier track the sources of illicit sales of the drugs. The most commonly abused and diverted prescription drugs are of course painkillers, but there are also amphetamines, sedatives, tranquilizers and more. Prescription drug abuse has surpassed street drugs in terms fo number of users as well as consequences such as loss of life.
If you know of someone in need of help for a problem with prescription drugs or any other substance, contact us today to find out more about effective intervention and treatment practices.